EN
CN
Overview
Management Team
Board of Directors
Advisory Board
Investment Institutions
About rAAV
R&D Technology Platform (EXACTE™)
Production Technology Platform (AAVANCE™)
Our Pipeline
Company News
FDA clears Investigational New Drug (IND) application for lead gene therapy product candidate, FT-001, for the treatment of a rare inherited eye disease leading to severe visual impairment that may result in blindness.
沪公网安备31011502401398号
Powered by Xinhongru
